Medical device cleansing wipes CaviWipes™ 2.0

pack of 160

The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis. Fully qualifies for the EPA's rigorous Emerging Viral Pathogen Claim. Features and Benefits Proven effective against SARS-CoV-2 on hard non-porous surfaces On EPA List Q* Qualifies for the EPA’s Emerging Viral Pathogens claim for all virus types (enveloped, large and small non-enveloped viruses) to meet current and potentially future infection prevention needs Enhanced Efficacy Claims - Effective against 60 relevant pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections. Excellent Material Compatibility - Compatible with most non-porous, hard surfaces commonly used in clinical settings Easy to use label - Makes it quick and easy to find critical information on efficacy, compatibility, and more 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris) Kill Claims 2 Minute Efficacy Against Non-Enveloped Viruses Adenovirus Type 2 Echovirus Type 11 Enterovirus Type 71 Human Rotavirus Norovirus Adenovirus Type 5 Rhinovirus Type 1A Pathogenic Fungi Candida auris Multi Drug-Resistant Bacteria Penicillin-Resistant Streptococcus pneumoniae (PRSP) Vancomycin-Resistant Enterococcus faecalis (VRE) Methicillin-Resistant Staphylococcus aureus (MRSA) Carbapenem-resistant Klebsiella pneumoniae (CRKP) Multidrug-Resistant Acinetobacter baumannii (MRAB) NDM-1 Enterobacter cloacae Vancomycin-Intermediate Staphylococcus aureus (VISA) Methicillin-Resistant Staphylococcus epidermidis